The DOI matches its Crossref record; 37 of the 37 references it cites were found in a registry or an index.
Subclinical Atrial Fibrillation and the Risk of Stroke
Open accessAbstract
BACKGROUND: One quarter of strokes are of unknown cause, and subclinical atrial fibrillation may be a common etiologic factor. Pacemakers can detect subclinical episodes of rapid atrial rate, which correlate with electrocardiographically documented atrial fibrillation. We evaluated whether subclinical episodes of rapid atrial rate detected by implanted devices were associated with an increased risk of ischemic stroke in patients who did not have other evidence of atrial fibrillation. METHODS: We enrolled 2580 patients, 65 years of age or older, with hypertension and no history of atrial fibrillation, in whom a pacemaker or defibrillator had recently been implanted. We monitored the patients for 3 months to detect subclinical atrial tachyarrhythmias (episodes of atrial rate >190 beats per minute for more than 6 minutes) and followed them for a mean of 2.5 years for the primary outcome of ischemic stroke or systemic embolism. Patients with pacemakers were randomly assigned to receive or not to receive continuous atrial overdrive pacing. RESULTS: By 3 months, subclinical atrial tachyarrhythmias detected by implanted devices had occurred in 261 patients (10.1%). Subclinical atrial tachyarrhythmias were associated with an increased risk of clinical atrial fibrillation (hazard ratio, 5.56; 95% confidence interval [CI], 3.78 to 8.17; P<0.001) and of ischemic stroke or systemic embolism (hazard ratio, 2.49; 95% CI, 1.28 to 4.85; P=0.007). Of 51 patients who had a primary outcome event, 11 had had subclinical atrial tachyarrhythmias detected by 3 months, and none had had clinical atrial fibrillation by 3 months. The population attributable risk of stroke or systemic embolism associated with subclinical atrial tachyarrhythmias was 13%. Subclinical atrial tachyarrhythmias remained predictive of the primary outcome after adjustment for predictors of stroke (hazard ratio, 2.50; 95% CI, 1.28 to 4.89; P=0.008). Continuous atrial overdrive pacing did not prevent atrial fibrillation. CONCLUSIONS: Subclinical atrial tachyarrhythmias, without clinical atrial fibrillation, occurred frequently in patients with pacemakers and were associated with a significantly increased risk of ischemic stroke or systemic embolism. (Funded by St. Jude Medical; ASSERT ClinicalTrials.gov number, NCT00256152.).
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Retrieved data provide an insight into the natural history and associated sequelae (Healey 2012, Kaplan 2019, Van Gelder 2017, Varma 2005).63,69,74,75”
From 2021 ISHNE/HRS/EHRA/APHRS Expert Collaborative Statement on mHealth in Arrhythmia Management: Digital Medical Tools for Heart Rhythm Professionals: From the International Society for Holter and Noninvasive Electrocardiology/Heart Rhythm Society/European Heart Rhythm Association/Asia-Pacific Heart Rhythm Society (2021) · cites this paper as Healey 2012
In the citing paper
“Device-detected, subclinical, atrial, high-rate episodes lasting 6 minutes to 24 hours are associated with increased stroke risk, but the absolute risk is considerably lower than expected based on risk factors alone (Glotzer 2003, Healey 2012, van Gelder 2017).74,75,79”
From 2021 ISHNE/HRS/EHRA/APHRS Expert Collaborative Statement on mHealth in Arrhythmia Management: Digital Medical Tools for Heart Rhythm Professionals: From the International Society for Holter and Noninvasive Electrocardiology/Heart Rhythm Society/European Heart Rhythm Association/Asia-Pacific Heart Rhythm Society (2021) · cites this paper as Healey 2012
In the citing paper
“AHRE are associated with an increased risk of overt AF (hazard ratio [HR] 5.56; 95% confidence interval [CI] 3.78-8.17;P < 0.001) and ischaemic stroke or systemic embolism (HR 2.49; 95% CI 1.28-4.85;P = 0.007).”
From 2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS (2016) · cites this paper as [141]
In the citing paper
“Depending on the risk profile of the population studied, such AHRE are detected in 10-15% of pacemaker patients.141”
From 2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS (2016) · cites this paper as [141]
In the citing paper
“AHRE are associated with an increased risk of overt AF (hazard ratio [HR] 5.56; 95% confidence interval [CI] 3.78-8.17;P < 0.001) and ischaemic stroke or systemic embolism (HR 2.49; 95% CI 1.28-4.85;P = 0.007).”
From 2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS (2016) · cites this paper as [141]
In the citing paper
“Traditional 24-h monitoring devices (i.e., Holter monitors) often do not detect symptomatic or clinically meaningful arrhythmias [6, 7].”
From Incidence and timing of potentially high-risk arrhythmias detected through long term continuous ambulatory electrocardiographic monitoring (2016) · cites this paper as [6]
Citations
Cites
Slamon, D. J., Leyland-Jones, B., Shak, S., Fuchs, H., Paton, V., Bajamonde, A., Fleming, T., Eiermann, W., Wolter, J., Pegram, M., et al. (2001) · New England Journal of Medicine · doi:10.1056/nejm200103153441101 · Cited by 11,500
Atrial fibrillation as an independent risk factor for stroke: the Framingham study
Wolf, P. A., Abbott, R. D., & Kannel, W. B. (1991) · Stroke · doi:10.1161/01.str.22.8.983 · Cited by 7,388
Gage, B. F., Waterman, A. D., Shannon, W., Boechler, M., Rich, M. W., & Radford, M. J. (2001) · JAMA · doi:10.1001/jama.285.22.2864 · Cited by 4,832
Pertuzumab plus Trastuzumab plus Docetaxel for Metastatic Breast Cancer
Baselga, J., Cortés, J., Kim, S.-B., Im, S.-A., Hegg, R., Im, Y.-H., Roman, L., Pedrini, J. L., Pienkowski, T., Knott, A., et al. (2012) · New England Journal of Medicine · doi:10.1056/nejmoa1113216 · Cited by 2,532
Epidemiologic assessment of chronic atrial fibrillation and risk of stroke: The fiamingham Study
Wolf, P. A., Dawber, T. R., Thomas, H. E., & Kannel, W. B. (1978) · Neurology · doi:10.1212/wnl.28.10.973 · Cited by 1,526
Atrial Fibrillation: A Major Contributor to Stroke in the Elderly: The Framingham Study
Wolf, P. A. (1987) · Archives of Internal Medicine · doi:10.1001/archinte.1987.00370090041008 · Cited by 1,108
Prevalence of atrial fibrillation in elderly subjects (the Cardiovascular Health Study)
Furberg, C. D., Psaty, B. M., Manolio, T. A., Gardin, J. M., Smith, V. E., & Rautaharju, P. M. (1994) · The American Journal of Cardiology · doi:10.1016/0002-9149(94)90363-8 · Cited by 1,096
Glotzer, T. V., Daoud, E. G., Wyse, D. G., Singer, D. E., Ezekowitz, M. D., Hilker, C., Miller, C., Qi, D., & Ziegler, P. D. (2009) · Circulation: Arrhythmia and Electrophysiology · doi:10.1161/circep.109.849638 · Cited by 879
Glotzer, T. V., Hellkamp, A. S., Zimmerman, J., Sweeney, M. O., Yee, R., Marinchak, R., Cook, J., Paraschos, A., Love, J., Radoslovich, G., et al. (2003) · Circulation · doi:10.1161/01.cir.0000057981.70380.45 · Cited by 750
von Minckwitz, G., du Bois, A., Schmidt, M., Maass, N., Čufer, T., de Jongh, F. E., Maartense, E., Zielinski, C. C., Kaufmann, M., Bauer, W., et al. (2009) · Journal of Clinical Oncology · doi:10.1200/jco.2008.19.6618 · Cited by 674
Flagged first, then by citations
Research works printed but not linked: 1
- 10.1001/archinte.147.9.1561 · DOI · Paper page
Cited by
Sorted by citations
Items 701–800 of 1,001
New Developments in Cardiac Pacemakers
Vardas, P. E., SIMANTIRAKIS, E. N., & KANOUPAKIS, E. M. (2013) · Circulation · doi:10.1161/circulationaha.112.000086 · Cited by 21
D’Anna, L., Abu‐Rumeileh, S., Merlino, G., Ornello, R., Foschi, M., Diana, F., Barba, L., Mastrangelo, V., Romoli, M., Lobotesis, K., et al. (2024) · Journal of the American Heart Association · doi:10.1161/jaha.124.034783 · Cited by 20
Winkle, R. A., Mead, R. H., Engel, G., Kong, M. H., & Patrawala, R. A. (2012) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2012.05.012 · Cited by 20
Stroke prevention in atrial fibrillation: comparison of recent international guidelines
Chao, T., Nedeljkovic, M. A., Lip, G. Y. H., & Potpara, T. (2020) · European Heart Journal Supplements · doi:10.1093/eurheartj/suaa180 · Cited by 20
“49).(33) Further analysis of the ASSERT trial demonstrated that the increased risk of ischaemic stroke or systemic embolism was only observed for patients with the longest episode of AHRE >24 h.”
BackgroundLiao, M., Yu, C., Lin, L., Pan, K.-H., Tsai, T.-H., Wu, Y.-C., & Liu, Y. (2022) · Scientific Reports · doi:10.1038/s41598-022-09181-1 · Cited by 21
Weil, E. L., Noseworthy, P. A., Lopez, C., Rabinstein, A. A., Friedman, P. A., Attia, Z. I., Yao, X., Siontis, K. C., Kremers, W. K., Christopoulos, G., et al. (2022) · Mayo Clinic Proceedings · doi:10.1016/j.mayocp.2022.01.026 · Cited by 20
CHA2DS2‐VASc and R2CHA2DS2‐VASc scores predict mortality in high cardiovascular risk population
D’Errico, M. M., Piscitelli, P. A., Mirijello, A., Santoliquido, M., Salvatori, M. P., Vigna, C., Vendemiale, G., Lamacchia, O., Fontana, A., Copetti, M., et al. (2022) · European Journal of Clinical Investigation · doi:10.1111/eci.13830 · Cited by 20
Larsen, B. S., Olsen, F. J., Andersen, D. M., Madsen, C. V., Møgelvang, R., Jensen, G. B., Schnohr, P., Aplin, M., Høst, N. B., Christensen, H., et al. (2022) · Journal of the American Heart Association · doi:10.1161/jaha.122.027031 · Cited by 20
Guichard, J.-B., Guasch, E., Roche, F., Costa, A. D., & Mont, L. (2022) · Frontiers in Physiology · doi:10.3389/fphys.2022.971691 · Cited by 21
“First, although the epidemiological relationship between AF and ischemic stroke is steady-grounded, there is a lack of clear temporal association between AF and stroke occurrence as assessed in the ASSERT (Healey et al., 2012) and TRENDS (Daoud et al., 2011) trials.”
BackgroundRisk Factors Associated With Atrial Fibrillation in Elderly Patients
Shin, J., Andrews, M., DeJean, L., Debski, N. D., Exarchakis, A., Fleming, J., Gandhi, R., Hum, C., Kalladanthyil, A., Maddigunta, R., et al. (2023) · Journal of Clinical Medicine Research · doi:10.14740/jocmr4884 · Cited by 21
“5fold increase in the risk of future clinical AF [33].”
BackgroundCryptogenic Stroke: How to Define It? How to Treat It?
Liberman, A. L., & Prabhakaran, S. (2013) · Current Cardiology Reports · doi:10.1007/s11886-013-0423-x · Cited by 20
Major advances in the treatment of stroke
Blanco, M., & Castillo, J. (2013) · Nature Reviews Neurology · doi:10.1038/nrneurol.2012.274 · Cited by 20
Current and Emerging Uses of Insertable Cardiac Monitors
Tomson, T. T., & PASSMAN, R. S. (2016) · Cardiology in Review · doi:10.1097/crd.0000000000000129 · Cited by 20
Why the ethical justification of randomized clinical trials is a scientific question
Shamy, M. C. F., & Fedyk, M. (2018) · Journal of Clinical Epidemiology · doi:10.1016/j.jclinepi.2017.12.026 · Cited by 20
Cardioembolic Stroke: Mechanisms and Therapeutics
Sacchetti, D. C., Furie, K. L., & Yaghi, S. R. (2017) · Seminars in Neurology · doi:10.1055/s-0037-1603465 · Cited by 21
Stroke in young adults: Incidence rate, risk factors, treatment and prognosis
González-Gómez, F. J., Pérez‐Torre, P., DeFelipe, A., Vera, R., Matute, C., Cruz-Culebras, A., Álvarez‐Velasco, R., & Masjuán, J. (2016) · Revista Clínica Española (English Edition) · doi:10.1016/j.rceng.2016.05.002 · Cited by 19
New Oral Anticoagulants in Nonvalvular Atrial Fibrillation
Fatima, U., Kulkarni, A., Stapleton, D. D., & Kaluski, E. (2016) · Clinical Cardiology · doi:10.1002/clc.22582 · Cited by 19
Recomendaciones preventivas cardiovasculares. Actualización PAPPS 2020
Orozco‐Beltrán, D., Cuixart, C. B., Sánchez, J. J. A., Banegas, J. R., Cuenca, A. M. C., Gil-Guillén, V. F., Rioboó, E. M., & Pérez, J. N. (2020) · Atención Primaria · doi:10.1016/j.aprim.2020.08.002 · Cited by 24
Chen, H., Zhang, F., Zhang, Y., & Yang, X. (2021) · Annals of Palliative Medicine · doi:10.21037/apm-21-3518 · Cited by 18
“Atrial fibrillation (AF), one of the most frequent cardiac rhythm disorders, is an independent risk factor for adverse cardiovascular outcomes (1), and some studies have revealed that this is a causal relationship (2,3).”
BackgroundZhu, X., Chen, R., Zhang, Y., Hu, J., Jiang, Y., Huang, K., Wang, J., Li, W., Shi, B., Chen, Y., et al. (2023) · The Science of The Total Environment · doi:10.1016/j.scitotenv.2023.163351 · Cited by 19
Electrocardiographic Predictors of Atrial Fibrillation
Chousou, P. A., Chattopadhyay, R. K., Tsampasian, V., Vassiliou, V. S., & Pugh, P. J. (2023) · Medical Sciences · doi:10.3390/medsci11020030 · Cited by 25
“However, the risk of thromboembolic complications is considered the same in both conditions [9].”
BackgroundWeng, L.-C. C., Khurshid, S. S., Gunn, S., Trinquart, L., Lunetta, K. L., Xu, H., NINDS Stroke Genetics Network*, Benjamin, E. J., Ellinor, P. T., Anderson, C. D., et al. (2023) · Stroke · doi:10.1161/strokeaha.122.041533 · Cited by 19
New-onset atrial fibrillation after percutaneous patent foramen ovale closure: a meta-analysis
Jurczyk, D., Macherey‐Meyer, S., Rawish, E., Stiermaier, T., Eitel, I., Frerker, C., & Schmidt, T. (2023) · Clinical Research in Cardiology · doi:10.1007/s00392-023-02263-8 · Cited by 19
“In ASSERT, subclinical AF was detected in 8% preceding their stroke, 16% after the event [38].”
BackgroundPPP1R12C Promotes Atrial Hypocontractility in Atrial Fibrillation
Perike, S., González-González, F. J., Abu-Taha, I., Damen, F. W., Hanft, L. M., Lizama, K. S., Aboonabi, A., Capote, A. E., Aguilar-Sánchez, Y., Levin, B. S., et al. (2023) · Circulation Research · doi:10.1161/circresaha.123.322516 · Cited by 20
“In these studies, we show for the first time that (1) human patients with AF demonstrate significantly increased atrial expression of PPP1R12C, (2) PPP1R12C is a major regulator of MLC2a phosphorylation in the heart, (3) PPP1R12C activity is modifiable at the MRCK site and affects changes in MLC2a phosphorylation, and…”
Bhavnani, S. P., Giedrimienė, D., Coleman, C. I., Guertin, D. C., Azeem, M., & Kluger, J. (2014) · Pacing and Clinical Electrophysiology · doi:10.1111/pace.12465 · Cited by 19
Benezet‐Mazuecos, J., Campal, J. M. R., & Farré, J. (2014) · Pacing and Clinical Electrophysiology · doi:10.1111/pace.12428 · Cited by 19
New Classification Scheme for Atrial Fibrillation Symptom Severity and Burden
Koci, F., Forbes, P., MANSOUR, M. C., Heist, E. K., Singh, J. P., Ellinor, P. T., & Ruskin, J. N. (2014) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2014.04.032 · Cited by 19
Secondary Prevention of Stroke in the Elderly: Focus on Drug Therapy
Arnan, M., Burke, G. L., & Bushnell, C. (2014) · Drugs & Aging · doi:10.1007/s40266-014-0212-2 · Cited by 20
Valenza, M. C., Baranchuk, A. M., Valenza‐Demet, G., Casaubón, T. M., Martin-Navajas, J. A., & Healey, J. S. (2014) · International Journal of Cardiology · doi:10.1016/j.ijcard.2014.03.156 · Cited by 19
Peripheral pulse measurement after ischemic stroke
Kallmünzer, B., Bobinger, T., Kahl, N., Kopp, M., Kurka, N., Hilz, M. J., Marquardt, L., Schwab, S., & Köhrmann, M. (2014) · Neurology · doi:10.1212/wnl.0000000000000690 · Cited by 19
Toplišek, J., Pernat, A., RUZIC, N., Robič, B., Šinkovec, M., Cvijić, M., & Geršak, B. (2015) · Pacing and Clinical Electrophysiology · doi:10.1111/pace.12791 · Cited by 19
Clinical Implications of Technological Advances in Screening for Atrial Fibrillation
Singh, N., Chun, S., Hadley, D., & Froelicher, V. F. (2018) · Progress in Cardiovascular Diseases · doi:10.1016/j.pcad.2018.01.007 · Cited by 19
Boriani, G., Healey, J. S., Schnabel, R. B., Lópes, R. D., Calkins, H. G., Camm, A. J., & Freedman, B. (2019) · International Journal of Cardiology · doi:10.1016/j.ijcard.2019.07.039 · Cited by 19
Flores, C. H., Bruña, V., Abizanda, P., Díez‐Villanueva, P., Formiga, F., Torres, R., Carreras, J., Ayala, R., Martín‐Sánchez, F. J., Bayés‐Genís, A., et al. (2020) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2020.09.008 · Cited by 19
Detection of Paroxysmal Atrial Fibrillation in Stroke/Tia Patients
Khan, M., & Miller, D. J. (2013) · Stroke Research and Treatment · doi:10.1155/2013/840265 · Cited by 18
Remote monitoring of pacemakers
Ploux, S., Strik, M., Varma, N., Eschalier, R., & Bordachar, P. (2021) · Archives of cardiovascular diseases · doi:10.1016/j.acvd.2021.06.007 · Cited by 18
Koplan, B. A., Winkelmayer, W. C., Costea, A., Roy‐Chaudhury, P., Tumlin, J. A., Kher, V., Williamson, D. E., Pokhariyal, S., Charytan, D. M., Williamson, D. E., et al. (2021) · Kidney International Reports · doi:10.1016/j.ekir.2021.10.001 · Cited by 18
“Conversely, a previous study revealed that monitor-detected, subclinical AF was associated with significantly increased risks of strokes and systemic embolism.(14)”
Upregulated miR-328-3p and its high risk in atrial fibrillation
Huang, H., Chen, H., Liang, X., Chen, X., Chen, X., & Chen, C. (2022) · Medicine · doi:10.1097/md.0000000000028980 · Cited by 18
Kim, S., Lee, S., Han, D., Jeong, I., Lee, H., Koh, Y., Chung, S. G., & Kim, K. (2023) · Internal Medicine · doi:10.2169/internalmedicine.0947-22 · Cited by 19
“Furthermore, AF increases the risk of stroke 5-fold (3), and 10-12% of all ischemic strokes are caused by AF-induced thrombus (4).”
BackgroundMoltó-Balado, P., Reverté‐Villarroya, S., Monclús-Arasa, C., Balado-Albiol, M. T., Baset-Martínez, S., Carot-Domenech, J., & Clua‐Espuny, J. L. (2023) · Biomedicines · doi:10.3390/biomedicines11071825 · Cited by 25
“Women are often older at the time of diagnosis and have a higher prevalence of hypertension and valvular heart disease [31], and AF is a stronger risk factor for cardiovascular disease and death in women compared with men [32].”
BackgroundBibliometric analysis of atrial fibrillation and ion channels
Zhu, X., Lv, M., Cheng, T., Zhou, Y., Yuan, G., Chu, Y., Luan, Y., Song, Q., & Hu, Y. (2024) · Heart Rhythm · doi:10.1016/j.hrthm.2024.01.032 · Cited by 18
Atrial fibrillation versus atrial myopathy in thrombogenesis: Two sides of the same coin?
Papakonstantinou, P. Ε., Rivera‐Caravaca, J. M., Chiarito, M., Ehrlinder, H., Iliakis, P., Gąsecka, A., Romiti, G. F., Parker, W. A., & Lip, G. Y. H. (2025) · Trends in Cardiovascular Medicine · doi:10.1016/j.tcm.2025.01.002 · Cited by 21
Emerging Role of Digital Technology and Remote Monitoring in the Care of Cardiac Patients
Banchs, J. E., & Scher, D. M. (2015) · Medical Clinics of North America · doi:10.1016/j.mcna.2015.02.013 · Cited by 19
Yodogawa, K., Seino, Y., Ohara, T., Hayashi, M., Miyauchi, Y., Katoh, T., & Mizuno, K. (2012) · Journal of Cardiology · doi:10.1016/j.jjcc.2012.08.013 · Cited by 18
Magnusson, P., & Mörner, S. (2020) · Journal of Cardiovascular Electrophysiology · doi:10.1111/jce.14792 · Cited by 18
“…of subclinical AF (>6 min) increased the risk of stroke by 2.5 ‐ fold and conferred a fivefold increased risk of AF verified by 12 ‐ lead ECG. 16 In a systematic review of HCM patients, the prevalence of AF was 22.5%, and annual incidence 3.8%; the prevalence of stroke and annual incidence…”
InfluentialSuwanwela, N., Chutinet, A., Autjimanon, H., Ounahachok, T., Decha-umphai, C., Chockchai, S., Indrabhakti, S., Kijpaisalratana, N., Akarathanawat, W., Travanichakul, S., et al. (2021) · International Journal of Cardiology: Heart & Vasculature · doi:10.1016/j.ijcha.2020.100709 · Cited by 20
“However, as many patients with AF have atypical or no symptoms [4], the initial presentation of AF may be hospitalization for a devastating stroke.”
BackgroundSubclinical Atrial Fibrillation: A Silent Threat with Uncertain Implications
Kashou, A. H., Adedinsewo, D. A., & Noseworthy, P. A. (2021) · Annual Review of Medicine · doi:10.1146/annurev-med-042420-105906 · Cited by 21
Ezekowitz, M. D., Ellenbogen, K. A., Dimarco, J., Kaszala, K., Boddy, A., Geba, G. P., & Koren, A. (2015) · Journal of Interventional Cardiac Electrophysiology · doi:10.1007/s10840-014-9966-z · Cited by 18
New-onset atrial fibrillation and thromboembolic risk: Cardiovascular syzygy?
Procter, N. E. K., Stewart, S., & Horowitz, J. D. (2015) · Heart Rhythm · doi:10.1016/j.hrthm.2015.12.010 · Cited by 17
Toni, D., Lorenzano, S., Strano, S., & on behalf of SAFFO Trial Investigators (2016) · International Journal of Stroke · doi:10.1177/1747493016631356 · Cited by 18
Are We Ready for Mass Screening to Detect Atrial Fibrillation?
Healey, J. S., & Sandhu, R. K. (2015) · Circulation · doi:10.1161/circulationaha.115.017288 · Cited by 18
Reiffel, J. A. (2016) · European Heart Journal · doi:10.1093/eurheartj/ehw014 · Cited by 18
Recent-onset atrial fibrillation: challenges and opportunities
Svennberg, E., Freedman, B., Andrade, J. G., Anselmino, M., Biton, Y., Boriani, G., Brandes, A., Buckley, C. M., Cameron, A. C., Clua‐Espuny, J. L., et al. (2025) · European Heart Journal · doi:10.1093/eurheartj/ehaf478 · Cited by 24
“21 25”
Atrial high-rate episodes: a comprehensive review
Simu, G. R., Roşu, R., Cismaru, G. L., Puiu, M., Guşetu, G., Minciună, I., Istrătoaie, S., Tomoaia, R., Zdrenghea, D. T., & Pop, D. (2021) · Cardiovascular journal of South Africa/Cardiovascular journal of Southern Africa · doi:10.5830/cvja-2020-052 · Cited by 17
“There are no randomised controlled trials published to date to guide anticoagulant therapy in patients with AHRE.”
BackgroundInfluentialLu, W., & Chen, J. (2021) · Scientific Reports · doi:10.1038/s41598-021-85301-7 · Cited by 17
Continuous 24-h Photoplethysmogram Monitoring Enables Detection of Atrial Fibrillation
Väliaho, E., Lipponen, J. A., Kuoppa, P., Martikainen, T. J., Jäntti, H., Rissanen, T. T., Castrén, M. K., Halonen, J., Tarvainen, M. P., Laitinen, T. M., et al. (2022) · Frontiers in Physiology · doi:10.3389/fphys.2021.778775 · Cited by 17
Atrial Fibrillation in the Setting of Acute Pneumonia: Not a Secondary Arrhythmia
Maisano, A., Vitolo, M., Imberti, J. F., Bonini, N., Albini, A., Valenti, A. C., Sgreccia, D., Mantovani, M., Malavasi, V. L., & Boriani, G. (2022) · Reviews in Cardiovascular Medicine · doi:10.31083/j.rcm2305176 · Cited by 17
Recomendaciones preventivas cardiovasculares. Actualización PAPPS 2022
Orozco‐Beltrán, D., Cuixart, C. B., Banegas, J. R., Gil-Guillén, V. F., Cuenca, A. M. C., Rioboó, E. M., Baldó, A. J., Vicuña, J., & Pérez, J. N. (2022) · Atención Primaria · doi:10.1016/j.aprim.2022.102444 · Cited by 64
Challenges of Anticoagulant Therapy in Atrial Fibrillation—Focus on Gastrointestinal Bleeding
Scridon, A., & Balan, A. I. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24086879 · Cited by 17
“This risk is present regardless of whether the arrhythmia is paroxysmal, persistent, or permanent [7].”
BackgroundXing, L. Y., Diederichsen, S. Z., Højberg, S., Krieger, D. W., Graff, C., Olesen, M. S., Nielsen, J. B., Brandes, A., Køber, L., Haugan, K., et al. (2023) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2023.08.042 · Cited by 17
Ho, I., Wong, C., Wong, Y., Lam, T.-H., Leung, I. S. H., Lin, M., Lui, D. T. W., Kwok, W. C., Tam, C. C., Chan, Y., et al. (2023) · JACC Asia · doi:10.1016/j.jacasi.2023.09.014 · Cited by 17
JCS / JHRS 2022 Guideline on Diagnosis and Risk Assessment of Arrhythmia
Takase, B., Ikeda, T., Shimizu, W., Abe, H., Aiba, T., Chinushi, M., Koba, S., KUSANO, K. F., Niwano, S., Takahashi, N., et al. (2024) · Journal of Arrhythmia · doi:10.1002/joa3.13052 · Cited by 19
Chinitz, L. A., Böhm, M., Evonich, R. F., Saba, S., Sangriogoli, R., Augostini, R. S., O’Neill, P. G., Fellows, C. L., Kim, M.-Y., Hettrick, D. A., et al. (2024) · JACC. Clinical electrophysiology · doi:10.1016/j.jacep.2024.04.035 · Cited by 17
Rankin, A. J., Tran, R., Abdul‐Rahim, A. H., RANKIN, A. C., & Lees, K. R. (2014) · QJM · doi:10.1093/qjmed/hcu177 · Cited by 18
Diving to the foot of an iceberg: The SEARCH for undiagnosed atrial fibrillation
Lane, D. A., & Potpara, T. (2014) · Thrombosis and Haemostasis · doi:10.1160/th14-05-0437 · Cited by 17
Jędrzejczyk‐Patej, E., Lenarczyk, R., Mazurek, M., Liberska, A., Przybylska-Siedlecka, K., Podolecki, T., Kowalczyk, J. P., Sokal, A., Leopold-Jadczyk, A., Kowalski, O., et al. (2015) · EP Europace · doi:10.1093/europace/euv095 · Cited by 17
Ogino, Y., Ishikawa, T., Ishigami, T., Matsumoto, K., Hosoda, J., Iguchi, K., Matsushita, H., Taguchi, Y., Horiguchi, Y., & Kimura, K. (2017) · Circulation Journal · doi:10.1253/circj.cj-16-1018 · Cited by 17
Tjahjadi, C., Hiemstra, Y. L., van der Bijl, P., Pio, S. M., Bootsma, M., Marsan, N. A., Delgado, V., & Bax, J. J. (2020) · European Heart Journal - Cardiovascular Imaging · doi:10.1093/ehjci/jeaa174 · Cited by 17
Murali, S., Brugger, N., Rincón, F. J., Mashru, M. R., Cook, S., & Goy, J. (2020) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2020.587945 · Cited by 17
“In addition, morbidity and mortality associated with subclinical AF are certainly underestimated and the conventional 24-h monitoring has a low sensitivity for the detection of such arrhythmia (8).”
BackgroundClinical review of sick sinus syndrome and atrial fibrillation
Chang, W., & Li, G. (2021) · Herz · doi:10.1007/s00059-021-05046-x · Cited by 17
Madsen, C. V., Park-Hansen, J., Holme, S. J. V., Irmukhamedov, A., Carranza, C. L., Greve, A. M., Al-Farra, G. J., Riis, R., Nilsson, B., Clausen, J. S. R., et al. (2022) · Seminars in Thoracic and Cardiovascular Surgery · doi:10.1053/j.semtcvs.2022.06.012 · Cited by 17
Wilton, S. B., Exner, D. V., Wyse, D. G., Yetisir, E., Wells, G. A., TANG, A. S. L., & Healey, J. S. (2016) · Circulation Arrhythmia and Electrophysiology · doi:10.1161/circep.115.003807 · Cited by 17
Engdahl, J., Holmén, A., Svennberg, E., Friberg, L., Frykman, V., Al‐Khalili, F., Rosenqvist, M., & Strömberg, U. (2016) · International Journal of Cardiology · doi:10.1016/j.ijcard.2016.07.198 · Cited by 17
Eickholt, C., Jungen, C., Drexel, T., Alken, F., Kuklik, P., Muehlsteff, J., Makimoto, H., Hoffmann, B. A., Kelm, M., Ziegler, D., et al. (2018) · Medical Science Monitor · doi:10.12659/msm.905209 · Cited by 19
Maervoet, J., Bossers, N., Borge, R. P., Hilpert, S. T., van Engen, A., & Smala, A. M. (2019) · Journal of Medical Economics · doi:10.1080/13696998.2019.1663355 · Cited by 17
When Low-Risk Atrial Fibrillation Is Not So Low Risk
Steinberg, B. A., & Piccini, J. P. (2018) · JAMA Cardiology · doi:10.1001/jamacardio.2018.1205 · Cited by 17
Kishima, H., Mine, T., Fukuhara, E., & Ishihara, M. (2020) · Journal of Cardiology · doi:10.1016/j.jjcc.2020.08.002 · Cited by 16
Garikapati, K., Turnbull, S., Bennett, R. G., Campbell, T. G., Kanawati, J., Wong, M. S., Thomas, S. P., Chow, C. K., & Kumar, S. (2022) · Heart Lung and Circulation · doi:10.1016/j.hlc.2022.08.001 · Cited by 18
Current perspectives on the clinical management of cryptogenic stroke
Yang, D., & Elkind, M. S. V. (2023) · Expert Review of Neurotherapeutics · doi:10.1080/14737175.2023.2192403 · Cited by 17
Saberniak, J., Skrebelyte-Strøm, L., Orstad, E. B., Hilde, J. M., Solberg, M. G., Rønning, O. M., Kjekshus, H., & Steine, K. (2023) · European Heart Journal Open · doi:10.1093/ehjopen/oead039 · Cited by 16
“The lack of consensus for cryptogenic stroke and transient ischemic attack (TIA) has prompted proposal of a new concept: ‘embolic strokes of undetermined source’ (ESUS),2 frequently associated with atrial cardiomyopathy.3 ESUS makes up to one-third of all ischemic strokes/TIA.4 Most cases of ESUS are thromboembolic,2…”
BackgroundInfluentialAtrial Fibrillation Detection and Load: Knowledge Gaps Related to Stroke Prevention
Smith, E. E., Yaghi, S. R., Sposato, L. A., Fisher, M., Broderick, J. P., Das, A. S., Elkind, M. S. V., Goldstein, L. B., Gurol, M. E., Kamel, H., et al. (2023) · Stroke · doi:10.1161/strokeaha.123.043665 · Cited by 17
Xu, Y., Ballew, S. H., Chang, A. R., Inker, L. A., Grams, M. E., & Shin, J. (2024) · Journal of the American Heart Association · doi:10.1161/jaha.123.034641 · Cited by 16
Actualización detallada de las guías de la ESC para el manejo de la fibrilación auricular de 2012
Camm, A. J., Lip, G. Y. H., Caterina, R. D., Savelieva, I., Atar, D., Hohnloser, S. H., Hindricks, G., Kirchhof, P. F., Bax, J. J., Baumgartner, H., et al. (2012) · Revista Española de Cardiología · doi:10.1016/j.recesp.2012.11.001 · Cited by 16
Goyal, S., Wang, L., Upender, R. P., Darbar, D., & Monahan, K. (2014) · Journal of Clinical Sleep Medicine · doi:10.5664/jcsm.3696 · Cited by 16
Asymptomatic atrial fibrillation in patients with atrial fibrillation and implanted pacemaker
Witkowski, M., Bissinger, A., Grycewicz, T., & Lubiński, A. (2016) · International Journal of Cardiology · doi:10.1016/j.ijcard.2016.10.097 · Cited by 16
Eckardt, L., Deneke, T., Diener, H., Hindricks, G., Hoffmeister, H. M., Hohnloser, S. H., Kirchhof, P. F., & Stellbrink, C. (2017) · Der Kardiologe · doi:10.1007/s12181-017-0141-5 · Cited by 16
The Impact of Atrial Fibrillation Clinical Subtype on Mortality
Leung, M., van Rosendael, P. J., Abou, R., Marsan, N. A., Leung, D. Y., Delgado, V., & Bax, J. J. (2017) · JACC. Clinical electrophysiology · doi:10.1016/j.jacep.2017.09.002 · Cited by 16
Chu, S., Jiang, J., Wang, Y., Sheng, Q., Zhou, J., & Ding, Y. (2019) · Heart & Lung · doi:10.1016/j.hrtlng.2019.07.007 · Cited by 16
van den Berg, N. W. E., Neefs, J., Berger, W. R., Boersma, L. V. A., van Boven, W. J., van Putte, B. P., Kaya, A., Kawasaki, M., Driessen, A. H. G., & de Groot, J. R. (2019) · Journal of Cardiovascular Medicine · doi:10.2459/jcm.0000000000000868 · Cited by 16
Holtzman, J. N., Wadhera, R. K., Choi, E. H., Zhao, T., Secemsky, E. A., Fraiche, A. M., Shen, C., & Kramer, D. B. (2020) · Heart Rhythm · doi:10.1016/j.hrthm.2020.05.044 · Cited by 16
Chen, Y., Chuang, J., Wang, H., Chen, H., Liu, W., & Yang, M. (2021) · Diagnostics · doi:10.3390/diagnostics11010090 · Cited by 16
Subclinical Atrial Fibrillation and the Risk of Recurrent Ischemic Stroke
Wachter, R., & Freedman, B. (2021) · Thrombosis and Haemostasis · doi:10.1055/s-0041-1726403 · Cited by 16
Doundoulakis, I., Gavriilaki, M., Tsiachris, D., Αρσένος, Π., Antoniou, C. K., Dimou, S., Σουλαϊδόπουλος, Σ., Farmakis, I. T., Akrivos, E., Stoiloudis, P., et al. (2021) · Cardiovascular Drugs and Therapy · doi:10.1007/s10557-021-07209-8 · Cited by 16
ECG abnormalities and stroke incidence
Agarwal, S. K., & Soliman, E. Z. (2013) · Expert Review of Cardiovascular Therapy · doi:10.1586/14779072.2013.811980 · Cited by 16
Sutton, R. (2013) · EP Europace · doi:10.1093/europace/eut108 · Cited by 16
Diagnosis, prognosis, and management of cryptogenic stroke
Zhang, C., & Kasner, S. E. (2016) · F1000Research · doi:10.12688/f1000research.7384.1 · Cited by 17
Blanco, V. G., de Torres, L. Á. P., Rioboó, E. M., Adell, M. Á. M., Rejano, J. M. P., González-Lama, J., Moruno, J. R., Álvarez, R. M., García, J., de Castroviejo, J. R., et al. (2016) · Medicina Clínica · doi:10.1016/j.medcli.2016.07.036 · Cited by 16
Robert, R., Porot, G., Vernay, C., Buffet, P., Fichot, M., Guénancia, C., Pommier, T., Mouhat, B., Cottin, Y., & Lorgis, L. (2018) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2018.04.029 · Cited by 16
Varma, N., Cygankiewicz, I., Turakhia, M. P., Heidbuchel, H., Hu, Y., Chen, L. Y., Couderc, J.-P., Cronin, E. M., Estep, J. D., Grieten, L., et al. (2021) · Cardiovascular Digital Health Journal · doi:10.1016/j.cvdhj.2020.11.004 · Cited by 16
“Device-detected, “subclinical” atrial high-rate episodes (AHRE) lasting 6 minutes to 24 hours are associated with increased stroke risk, but the absolute risk is considerably lower than expected based on risk factors alone (Glotzer 2003, Healey 2012, van Gelder 2017).”
BackgroundAtrial Fibrillation Begets Myocardial Infarction
Dukes, J. W., & Marcus, G. M. (2013) · JAMA Internal Medicine · doi:10.1001/jamainternmed.2013.11392 · Cited by 16
Metadata
- Authors
- Healey, J. S., Connolly, S. J., Gold, M. R., Israel, C. W., Van Gelder, I. C., Capucci, A., Lau, C. P., Fain, E., Yang, S., Bailleul, C., Morillo, C. A., Carlson, M., Themeles, E., Kaufman, E. S., & Hohnloser, S. H.
- Affiliations
- Population Health Research Institute (CA)
- Medical University of South Carolina (US)
- Goethe University Frankfurt (DE)
- Marche Polytechnic University (IT)
- Queen Mary Hospital (CN)
- MetroHealth (US)
- ORCID
- Venue
- New England Journal of Medicine
- Publisher
- Massachusetts Medical Society
- Published
- 2012-01-12
- Volume
- 366
- Issue
- 2
- Pages
- 120-129
- ISSN
- 0028-4793 (ISSN-L)
- 1533-4406
- OpenAlex
- W2154658516
- Cited by
- 2,100
- References
- 37
- Citations by year
- 2026: 87 · 2025: 104 · 2024: 137 · 2023: 116 · 2022: 134 · 2021: 153 · 2020: 148 · 2019: 162 · 2018: 154 · 2017: 154 · 2016: 162 · 2015: 146 · 2014: 181 · 2013: 133 · 2012: 124
- FWCI
- 120.21
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- New England Journal of Medicine (publishedVersion)
- PubMed (publishedVersion)
- University of Groningen research database (University of Groningen / Centre for Information Technology) (publishedVersion)
- Università Politecnica delle Marche (Università Politecnica delle Marche) (submittedVersion)
- University of Groningen research database (University of Groningen / Centre for Information Technology) (submittedVersion)
- Topics
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Atrial Fibrillation Management and Outcomes
- Health Sciences › Medicine › Clinical Neurology › Acute Ischemic Stroke Management
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiac pacing and defibrillation studies
- Keywords
- subclinical atrial fibrillation, atrial tachyarrhythmia, ischemic stroke, systemic embolism, atrial overdrive pacing, atrial fibrillation risk, hypertension, elderly patients, population attributable risk, stroke prevention, cardiac implantable electronic devices, atrial fibrillation detection, atrial fibrillation prevention
- MeSH terms
- Aged, Aged, 80 and over, Atrial Fibrillation, Cardiac Pacing, Artificial, Embolism, Female, Humans, Hypertension, Male, Pacemaker, Artificial, Prospective Studies, Risk, Defibrillators, Implantable, Stroke
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review